Initiator Pharma: Set To Initiate New Phase I Study - Redeye

Redeye leaves a comment following Initiator Pharma’s announcement earlier today stating that it will initiate a phase I pharmacokinetic study in healthy subjects, evaluating new oral solid dosage forms of IP2015.

Länk till analysen i sin helhet: https://www.redeye.se/research/869448/initiator-pharma-set-to-initiate-new-phase-i-study?utm_source=finwire&utm_medium=RSS